Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice ; volume:9 ; number:1 ; day:1 ; month:4 ; year:2021 ; pages:1-16 ; date:12.2021
Acta Neuropathologica Communications ; 9, Heft 1 (1.4.2021), 1-16, 12.2021

Creator: Frew, Jonathan
Nygaard, Haakon Berge

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-021-01158-x

URN: urn:nbn:de:101:1-2021051720422594823790

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.20252025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Frew, Jonathan
Nygaard, Haakon Berge
SpringerLink (Online service)

Other Objects (12)

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin deficient mice develop nephrogenic diabetes insipidus

Increased fat taste preference in progranulin-deficient mice

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Related objects

Reset password